Vertex Pharmaceuticals, Inc. (VRTX)

441.20 +5.55 (+1.27%) USD  |  NASDAQ  |  Apr 17, 16:00
442.99 +1.79 (+0.41%) Pre-Market: 20:00
More

Vertex Pharmaceuticals Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Moderna, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade